Browse by Poster Presenter

Skip to main content

ASCPT 2023 Annual Meeting Main banner

Tweets by ASCPT 2023 Annual Meeting

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

D
Dao, Justine

Galapagos SASU
PI-064 - EFFECTS OF GLPG3970 ON SULFASALAZINE AND METHOTREXATE PHARMACOKINETICS IN HEALTHY ADULTS: RESULTS OF TWO OPEN-LABEL, PHASE I, DRUG–DRUG INTERACTION STUDIES.
Justine Dao
Favorite
Darwish, Mona

Acadia Pharmaceuticals Inc.
EP-023 - POPULATION PHARMACOKINETIC MODELLING TO CONFIRM WEIGHT-BASED BANDED DOSING AND EXPOSURE-RESPONSE EFFICACY ANALYSES TO SUPPORT TROFINETIDE TREATMENT IN RETT SYNDROME.
Mona Darwish
Favorite
EP-024 - POPULATION PHARMACOKINETIC MODELLING TO PREDICT TROFINETIDE EXPOSURE AND EXPOSURE-RESPONSE SAFETY ANALYSES IN GIRLS WITH RETT SYNDROME AGED 2–4 YEARS.
Mona Darwish
Favorite
Datta-Mannan, Amita

Eli Lilly and Company
EP-029 - IDENTIFICATION OF A SAFE AND TOLERABLE CARBAMAZEPINE DOSING PARADIGM THAT FACILITATES EFFECTIVE CYP3A INDUCTION EVALUATION.
Amita Datta-Mannan
Favorite
Dauki, Anees

Gilead Sciences
PII-083 - POPULATION PHARMACOKINETICS OF GS-3583 IN HEALTHY VOLUNTEERS AND PATIENTS WITH ADVANCED SOLID TUMORS.
Anees Dauki
Favorite
Davies, Rupert

Alpine Immune Sciences
PI-059 - EARLY CLINICAL PK/PD MODELING AND SIMULATION OF ALPN-303, A POTENT DUAL BAFF/APRIL ANTAGONIST, TO SUPPORT FIRST-IN-DISEASE CLINICAL TRIALS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER B CELL-RELATED DISEASES.
Rupert Davies
Favorite
Day, Jeanine

University at Buffalo
PT-008 - INFLUENCE OF MCT6 ON PLATINUM DISPOSITION AND OTOTOXICITY.
Jeanine Day
Favorite
de Hoop-Sommen, Marika

Radboud University Medical Center
PII-103 - REGISTERED DIGOXIN DOSES FOR CHILDREN DO NOT LEAD TO OPTIMAL EXPOSURE: A PBPK STUDY.
Marika de Hoop-Sommen
Favorite
Diao, Lei

Fosun Pharma
PI-105 - POPULATION PHARMACOKINETICS OF FS-1502, AN HER2 ANTIBODY-DRUG CONJUGATE (ADC), IN PATIENTS WITH HER2 EXPRESSED ADVANCED MALIGNANT SOLID TUMORS.
Lei Diao
Favorite
Dogterom, Peter

QPS Netherlands
PII-007 - EXPERIENCES OF CEREBROSPINAL FLUID COLLECTION, EITHER BY SERIAL SAMPLING OR BY LUMBER PUNCTURES, IN CLINICAL PHARMACOLOGY RESEARCH.
Peter Dogterom
Favorite
Dong, Min

Cincinnati Children's Hospital Medical Center
PI-087 - DEVELOPMENTAL CHANGES OF HYDROXYUREA PHARMACOKINETICS IN CHILDREN WITH SICKLE CELL ANEMIA.
Min Dong
Favorite
PWIV-003 - DEVELOPMENTAL CHANGES OF HYDROXYUREA PHARMACOKINETICS IN CHILDREN WITH SICKLE CELL ANEMIA.
Min Dong
Favorite
Drabison, Thomas

The Ohio State University
PI-019 - IDENTIFICATION OF S100A9 AS A THERAPEUTIC TARGET IN PACLITAXEL-INDUCED PERIPHERIAL NEUROPATHY (PIPN).
Thomas Drabison
Favorite
Dunbar, Joi

Sage Therapeutics, Inc.
PI-072 - IN VITRO AND IN VIVO POTENTIAL OF ZURANOLONE TO CAUSE CYP-MEDIATED DRUG-DRUG INTERACTIONS.
Joi Dunbar
Favorite
PII-089 - THE EFFECTS OF CYP3A INDUCTION AND INHIBITION ON ZURANOLONE PHARMACOKINETICS IN HEALTHY ADULTS.
Joi Dunbar
Favorite
Dunvald, Ann-Cathrine

University of Southern Denmark
PT-027 - DO GLUCOSE-LOWERING DRUGS AFFECT DRUG METABOLISM AND WARFARIN EFFICACY?
Ann-Cathrine Dunvald
Favorite
Duong, Quoc-Viet

US Food and Drug Administration
PI-078 - LEVERAGING A DERMAL PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL OF A TOPICAL CREAM TO EXPLORE THE BIOEQUIVALENCE SAFE SPACE FOR INFLUENTIAL FORMULATION ATTRIBUTES.
Quoc-Viet Duong
Favorite